These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10538905)

  • 1. Therapeutic breakthroughs in the millennium: what to look for in the next two decades. Part 2: New therapeutics reverse old thinking.
    Davidson S
    Health Forum J; 1999; 42(2):61-3. PubMed ID: 10538905
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns raised over declining antiinfectives R&D.
    Fox JL
    Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in antimicrobial drug development: implications for the future.
    Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
    Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic breakthroughs in the new millennium: what to look for in the next two decades. Part 1: New answers for cancer, drug resistance, food poisoning.
    Davidson S
    Health Forum J; 1999; 42(1):54-6. PubMed ID: 10387918
    [No Abstract]   [Full Text] [Related]  

  • 5. IL-1 trap go-ahead.
    Ratner M
    Nat Biotechnol; 2008 May; 26(5):485. PubMed ID: 18464767
    [No Abstract]   [Full Text] [Related]  

  • 6. The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface.
    Enna SJ; Williams M
    Adv Pharmacol; 2009; 57():xi-ii. PubMed ID: 19945649
    [No Abstract]   [Full Text] [Related]  

  • 7. The problem of new uses.
    Eisenberg RS
    Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinued drugs in 2008: anti-infectives.
    Ryder NS
    Expert Opin Investig Drugs; 2010 Jan; 19(1):1-21. PubMed ID: 20001552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
    Cornell S
    Adv Nurse Pract; 2000 Dec; 8(12):62-4. PubMed ID: 12397912
    [No Abstract]   [Full Text] [Related]  

  • 10. Withdrawal syndrome.
    Nat Med; 2004 Nov; 10(11):1143. PubMed ID: 15516887
    [No Abstract]   [Full Text] [Related]  

  • 11. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development.
    Spellberg B; Miller LG; Kuo MN; Bradley J; Scheld WM; Edwards JE
    Infection; 2007 Jun; 35(3):167-74. PubMed ID: 17565458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study reveals secrets to faster drug development.
    Frantz S
    Nat Rev Drug Discov; 2006 Nov; 5(11):883. PubMed ID: 17117519
    [No Abstract]   [Full Text] [Related]  

  • 13. Market watch: upcoming market catalysts in Q2 2011.
    Jeng R
    Nat Rev Drug Discov; 2011 Apr; 10(4):248. PubMed ID: 21455226
    [No Abstract]   [Full Text] [Related]  

  • 14. New therapies from old medicines.
    Chen ST; Dou J; Temple R; Agarwal R; Wu KM; Walker S
    Nat Biotechnol; 2008 Oct; 26(10):1077-83. PubMed ID: 18846070
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-inflammatory inflames Centocor's profits.
    Glaser V
    Nat Biotechnol; 1998 Oct; 16(10):900. PubMed ID: 9788334
    [No Abstract]   [Full Text] [Related]  

  • 17. Can we help one billion sick people?
    Maliski E; Gund P; Brown F
    Curr Opin Drug Discov Devel; 2008 May; 11(3):301-2. PubMed ID: 18428082
    [No Abstract]   [Full Text] [Related]  

  • 18. The vexations of Vioxx.
    Sibbald B
    CMAJ; 2006 Feb; 174(4):444-5. PubMed ID: 16477046
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of new antibiotics refuted by recent study.
    Scott L
    Mod Healthc; 1994 Aug; 24(32):144. PubMed ID: 10135371
    [No Abstract]   [Full Text] [Related]  

  • 20. Market watch: upcoming market catalysts in Q1 of 2010.
    Rosenthal J
    Nat Rev Drug Discov; 2010 Jan; 9(1):11. PubMed ID: 20043022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.